<DOC>
	<DOCNO>NCT00491322</DOCNO>
	<brief_summary>The purpose project determine treat vitamin D deficiency decrease insulin resistance improve insulin secretion healthy volunteer . Additionally , project investigate treat vitamin D deficiency affect new phosphate-regulating hormone call FGF-23 .</brief_summary>
	<brief_title>Vitamin D Deficiency , Insulin Resistance FGF-23</brief_title>
	<detailed_description>Vitamin D deficiency hypovitaminosis D , define serum 25 hydroxyvitamin D &lt; = 20 ng/mL , prevalent several population United States , specifically minorities elderly . Causes vitamin D deficiency include lack exposure sunlight , malnutrition , drug alter vitamin D metabolism absorption . Vitamin D essential factor many organ system . Data suggest vitamin D require normal insulin secretion pancreas . Specifically , animal study demonstrate treatment vitamin D deficiency improve insulin secretion . In human , less consensus impact vitamin D deficiency insulin resistance . In one study middle-aged patient Type 2 diabetes mellitus , association see serum 25 hydroxyvitamin D level measure insulin resistance . However , large study young glucose tolerant subject , serum 25 hydroxyvitamin D level associate insulin secretion insulin resistance . These data suggest treatment vitamin D deficiency may delay prevent development insulin resistance , thus diabetes mellitus type 2 . Repletion common vitamin deficiency could therefore major public health implication prevention diabetes mellitus . Fibroblast growth factor 23 ( FGF-23 ) newly discover phosphaturic hormone regulate dietary serum phosphate . Hormonal regulation FGF-23 , however , largely unknown . Recent data suggest vitamin D play important role regulation FGF-23 . Some group show inactivation vitamin D receptor gene decrease serum FGF-23 level mouse ; administration 1,25 dihydroxyvitamin D stimulate transcription FGF-23 gene vitro . Little known , however , regulation FGF-23 vitamin D human . Phosphate critical bone mineralization , muscle function , signal transduction , creation utilization energy . Vitamin D deficiency result phosphate malabsorption , osteomalacia increase risk fracture . Enhanced understand regulation new phosphate-regulating hormone , FGF-23 , advance field phosphate metabolism .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Age 18 45 yr Serum 25OHD &lt; = 20 ng/mL At least 1 menses last 3 month ( female ) normal serum testosterone ( male ) Significant cardiac , hepatic , oncologic , psychiatric disease History diabetes mellitus , malabsorption , kidney stone , recent alcohol excess/abuse ( 15 drink per week last month ) Fasting glucose &gt; 126 mg/dl 2 hour OGTT &gt; 200 mg/dl Use medication know affect serum phosphate level include phosphatebinding antacid , sodium etidronate , calcitonin , excessive dos vitamin D ( &gt; 1000 unit per day ) , excessive dos vitamin A ( &gt; 20,000 units/day ) , calcitriol , growth hormone , anticonvulsant Use metformin insulin sensitize agent Serum calcium &lt; 8 &gt; 11 mg/dL , creatinine &gt; 1.5 mg/dL , Hgb &lt; 11 gm/dL Liver function test &gt; 2 time upper limit normal TSH &lt; 0.1 &gt; 7 uU/mL WBC &lt; 2,000 &gt; 15,000/cmm Platelet count &lt; 100,000 &gt; 500,000/cum Hormone replacement therapy testosterone use Urine uhCG positive ( female ) , testosterone &lt; 270 ng/dL ( male )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Vitamin D deficiency</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Diabetes mellitus</keyword>
	<keyword>FGF-23</keyword>
	<keyword>FGF23</keyword>
	<keyword>Phosphate</keyword>
</DOC>